Back to search

Article

Nanobiopolymer for Direct Targeting and Inhibition of EGFR Expression in Triple Negative Breast Cancer

2020-06-14

Abstract excerpt

<p>AbstractTreatment options for triple negative breast cancer (TNBC) are generally limited to cytotoxic chemotherapy. Recently, antiepidermalgrowth factor receptor (EGFR) therapy has been introduced for TNBC patients. We engineered a novelnanobioconjugate based on a poly(b-L-malic acid) (PMLA) nanoplatform for TNBC treatment. The nanobioconjugate carriesanti-tumor nucleosome-specific monoclonal antibody (mAb) 2C5...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
cae1b4dc-9925-5c2c-987d-267c642e188a
DOI
10.31234/osf.io/p6tuk
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Nanobiopolymer for Direct Targeting and Inhibition of EGFR Expression in Triple Negative Breast CancerDOI 10.31234/osf.io/p6tuk
Select a neighboring publication to make it the new centre.